• Activity INFORMATION

  Overview

  We live in an "Opioid Epidemic" where someone dies approximately every 15 minutes from prescription drug overdose. So just how do we end this "Opioid Epidemic" or at least, how do we as healthcare professionals contribute to the progress of society in the right direction? In this monograph, we will review overall pain management etiology, specific opioid medication pharmacological concepts, opioid overdose reversal treatments, and not only how to identify drug seeking and diversion behaviors, but possible actions to take when the behaviors are suspected. We will also review West Virginia specific controlled substance laws, trends, and the Controlled Substances Monitoring Program. Unlike opioids, this monograph is intended to open one's eyes, elevate blood pressure and/or heart rate, and increase cognition (in relation to the Opioid Epidemic).

   

  This program has been APPROVED for WV Pharmacists to fulfill the requirement of Drug Diversion.  WV-2017-05-10-CE Drug Diversion

  Rating

     4.50  out of 5

  Handouts

  • Homestudy PDF :   HomestudyPDF17096H04.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Describe when and how to initiation, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; discontinuation and tapering of opioids; medication therapy management and collaborative practice; and appropriate documentation in medical records.

  Describe the etiology and epidemiology of chronic pain.

  Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.

  Identify West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.

  Explain how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-l.

  Explain the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.

  Describe the best practices for identifying “red flag” patient drug seeking & diversion behaviors.

  Explain how to be compliant with federal and state controlled substances laws.

  Explain the best practices for working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.

  Pharmacy Technician

  Identify West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.

  Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.

  Identify the best practices for the use of opioid medications based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; & discontinuation and tapering of opioids.

  Explain how to be compliant with federal and state controlled substance laws

  Explain how to ensure that the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment are in place within a pharmacy practice

  Describe the etiology and epidemiology of chronic pain.

  Explain the best practices for working with patients, prescribers, law enforcement, and other as appropriate, concerning patients suspected of drug seeking behavior and diversion

  Describe the best practices for identifying "red flag" patient drug seeking & diversion behaviors

  Explain how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-l.

  Nurse

  Explain how to register with and use the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-l.

  Identify West Virginia statistical trends in prescription drug abuse and deaths, with special attention to the misuse of opioid medications.

  Describe when and how to initiation, continue, or discontinue opioid medications for the management of patients experiencing pain based on available pain management guidelines including the CDC Chronic Pain Opioid Guidelines. Concepts will include a review of patient evaluation and risk assessment tools; pain treatment objectives; patient and provider(s) agreements; urine screenings; pill counts; patient education on the safe use, storage and disposal of controlled substances; drug interactions; toxicities; discontinuation and tapering of opioids; medication therapy management and collaborative practice; and appropriate documentation in medical records.

  Identify non-pharmacological and pharmacological (both opioid and non-opioid) pain treatments.

  Explain how to be compliant with federal and state controlled substances laws.

  Describe the etiology and epidemiology of chronic pain.

  Describe the best practices for identifying “red flag” patient drug seeking & diversion behaviors.

  Explain the best practices for working with patients, prescribers, law enforcement, and others as appropriate, concerning patients suspected of drug seeking behavior and diversion.

  Explain the best practices for the supply of, and education on, naloxone as an opioid overdose reversal treatment.

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-606442

  Universal Activity Number

  Pharmacist 0798-0000-17-096-H04-P
  Pharmacy Technician 0798-0000-17-096-H04-T
  Nurse 0798-0000-17-096-H04-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mark  Garofoli, PharmD, MBA, BCGP, CPE Assistant Professor, West Virginia University School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).